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tiving lobar lung transplantation was developed as an al-
ternative to cadaver lung transplantation because of the
ontinuing shortage of acceptable donor organs.1,2 In living
obar lung transplantation, two healthy donors are selected—
ne to undergo removal of the right lower lobe and the other
o undergo removal of the left lower lobe. These lobes are
hen implanted in the recipient in place of whole right and
eft lungs. This technique has proven to be beneficial to a
roup of patients who would otherwise have died due to
isease while awaiting lungs from a conventional deceased
onor.3 Living lobar lung transplant candidates should meet
he standard criteria for deceased donor lung transplanta-
ion.4 Potential recipients should have the expectation that
hey would die or become unsuitable recipients before de-
eased donor lungs become available. Cystic fibrosis has been
he most common indication for living lobar lung transplan-
ation. Other indications have included primary pulmonary
ypertension, pulmonary fibrosis, bronchopulmonary dys-
lasia, obliterative bronchiolitis, lymphangioleiomyomato-
is, and idiopathic interstitial pneumonia.2,5 Recently a sur-
ival benefit has been reported in pediatric living donor lobar
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The goals of donor selection are to identify donors with
xcellent health, adequate pulmonary reserve for lobar dona-
ion, an emotional attachment to the recipient, and a willing-
ess to accept the risks of donation without coercion. Our
riteria for donation also include age between 18 and 55, no
istory of thoracic procedures on the side to be donated, and
xcellent general health. Donors taller than the recipient are
avored over donors of the same or lesser height, as they have
he potential to provide larger lobes. The right lower lobe is
sually selected from the larger donor, whereas, if the donors
re of the same height, the donor with the more complete
ssure on the left is chosen to donate that side. Occasionally,
n acceptable donor will have a history of prior thoracic
rocedures, trauma, or infection. In this case, the contralat-
ral side is chosen for donation. At our center, computed
omographic (CT) scanning and spirometry are used to esti-
ate lung volume, although the optimal method of deter-
ining an appropriate size match between donor and recip-
ent remains to be defined and further improvements in this
ethodology are warranted. For pediatric recipients, care
ust be exercised to ensure that the lower lobe is not over-
ized. The performance of living lobar lung transplantation
nvolves three simultaneous operations: two donor lobecto-
ies and the recipient bilateral pneumonectomy and lobar
mplantation. The lobar vascular and bronchial anatomy of
he right and left lower lobe are the most suitable for lobar
ransplantation.
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Figure 1 After induction of anesthesia, fiber-optic bronchoscopy is performed to exclude mucosal abnormalities or
alterations in bronchial anatomy. The single-lumen endotracheal tube is subsequently replaced with a double-lumen
tube, and the patient is positioned in the appropriate lateral decubitus position. Prostaglandin E1 is administered
intravenously to dilate the pulmonary bed and the dosage is adjusted to maintain a systolic blood pressure of 90 to 100
mm Hg. The lobe must be removed with an adequate cuff of bronchus and pulmonary artery and vein to permit
successful implantation into the recipient, while allowing closure of these structures without compromise in the donor.
The donor lung is deflated and the chest is entered through a standard posterolateral thoracotomy through the fourth
or fifth interspace. The inferior pulmonary ligament is taken down and the pleura is opened around the hilum.
Dissection in the fissure characterizes anatomic variants and identifies the pulmonary arteries to the right lower and
right middle lobes. The relationship between the superior segmental artery to the right lower lobe and middle lobe
artery should be visualized. Commonly, the middle lobe has two arteries with the smaller artery having a more distal
origin than the superior segmental artery to the lower lobe. In this case, the smaller artery may be ligated and divided.
Ideally, there will be sufficient distance between the takeoff of the middle lobe artery and the superior segmental artery
of the right lower lobe to permit placement of a vascular clamp distal to the middle lobe artery, thus enabling a sufficient
vascular cuff for the pulmonary arterial anastomosis at implantation.
Living lobar lung transplantation 49Figure 2 After confirming that the inferior pulmonary vein does not receive venous drainage from the right middle lobe,
the pericardium surrounding the inferior pulmonary vein is incised. This dissection allows a vascular clamp to be
placed on the left atrium and the inferior pulmonary vein to be cut with an adequate cuff on the donor lobe.
50 M.K. McLean, M.L. Barr, and V.A. StarnesFigure 3 When the vascular dissections are complete, the fissures are stapled using a 75-mm nonvascular stapler or a
45-mm thoracoscopic stapler. Five to ten thousand units of heparin and 500 mg of methylprednisolone are adminis-
tered intravenously and the lung is reinflated and ventilated for 5 to 10 minutes to permit the drugs to circulate through
the lung. The lung is then deflated. To avoid vascular congestion of the pulmonary allograft, a vascular clamp is placed
first on the pulmonary artery and subsequently on the left atrial side of the inferior pulmonary vein, optimizing the
length of the venous cuff for pulmonary venous anastomosis. The pulmonary artery is transected at a point that will
allow an adequate vascular cuff for anastomosis while leaving enough length to permit repair without compromising
the remaining pulmonary arterial branches. The inferior pulmonary vein is transected with a small cuff of left atrium.
The bronchus to the right lower lobe should now be exposed. Minimizing dissection around the bronchus preserves
blood supply to both the donor lobe and the remaining lung. The right middle lobe bronchus is identified and the
bronchus to the lower lobe is tangentially transected. The incision begins in the bronchus intermedius above the
bronchus to the superior segment of the right lower lobe and moves obliquely to a point just below the takeoff of the
right middle lobe bronchus.
Division of the pulmonary vessels and bronchus should be performed expeditiously to limit the warm ischemic time
of the allograft. When separated, the donor lobe is wrapped in a cold, moist sponge and taken to a separate, sterile table
for preservation. The donor pulmonary artery is repaired in two layers with a running polypropylene suture and the
pulmonary vein/left atrium is closed in a similar fashion. The bronchus is closed with interrupted polypropylene, being
careful to avoid narrowing of the bronchus intermedius or infolding of the middle lobe carina. Resecting a small wedge
of cartilage at the orifice of the middle lobe may facilitate closure. The bronchial suture line is covered with a pleural flap
to separate the arterial and bronchial suture lines. Alternatively, use of a pedicled pericardial fat pad has been
described.7 Two chest tubes are placed in the pleural space and the chest is closed in the standard fashion.
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Living lobar lung transplantation 51igure 4 For the donor of the left lower lobe, the left
hest is opened using a standard posterolateral thora-
otomy through the fourth or fifth interspace. The
ung is examined in a similar fashion to that described
or the donor of the right lower lobe. The inferior
ulmonary ligament is taken down and the pleura is
pened around the hilum. Dissection in the fissure
efines the vascular anatomy. The relationship be-
ween the superior segmental artery to the left lower
obe and the anteriorly positioned lingular artery is
valuated. The lingular artery may be ligated and di-
ided if it is of small size and its origin is too far distal
o the artery to the superior segment of the lower lobe.
f the significance of this artery is uncertain, the anes-
hesiologist can inflate and deflate the lung while this
rtery is occluded. Dissection of the pulmonary artery
o the lower lobe should enable placement of a vascu-
ar clamp proximal to the artery supplying the supe-
ior segment of the lower lobe. The pericardium
round the inferior pulmonary vein is opened circum-
erentially and the fissures are completed with a non-
ascular stapler.Figure 5 When the dissection is complete, the lung is rein-
flated and ventilated for 5 to 10 minutes as described for the
right side. Heparin and methylprednisolone are adminis-
tered. The lung is subsequently deflated and the pulmonary
artery and vein are clamped and transected in the sequence
described for the right lung. The exposed bronchus is fol-
lowed upward until the lingular bronchus is identified. Care
must be taken to avoid skeletonizing the bronchus as this may
compromise healing in the recipient. The tangential transec-
tion begins at the base of the upper lobe bronchus and ends
superiorly to the bronchus to the superior segment of the left
lower lobe. The donor lobe is then taken to a separate table for
preservation and storage. The pulmonary vessels and bron-
chus are repaired in a manner similar to that described above.
52 M.K. McLean, M.L. Barr, and V.A. StarnesFigure 6 The recipient operation commences in a third operating room while the donor operations are being performed.
The patient is positioned supine and the arms are padded and placed in an extended and abducted position on an
overhead frame. The operation is performed through a transverse thoracosternotomy (clamshell) incision, which
provides exposure for cardiac cannulation and adequate access to the pleural spaces. All of the procedures at our center
have all been preferentially performed while on cardiopulmonary bypass, often because of the recipient’s critical
condition, as well as to minimize the risk of pulmonary edema while exposing one lobe to the entire cardiac output
while the other lobe is implanted. Use of cardiopulmonary bypass prevents spillage of purulent secretions from the
second native lung and allows simultaneous reperfusion of both lobes in a controlled fashion. Hilar dissection and lysis
of adhesions are completed before heparinization and cardiopulmonary bypass. The pleural cavity of cystic fibrosis
patients is irrigated thoroughly with antibacterial and antifungal solutions. Dissection of the pulmonary artery and
veins is performed as distally as possible to optimize cuff length for the anastomoses. When the dissection is complete,
cardiopulmonary bypass is initiated and the pulmonary vasculature is divided. The pulmonary veins are divided
between stapling devices while the pulmonary artery is doubly ligated and divided. The bronchus is divided with a
stapling device at the level of the takeoff of the upper lobe bronchus. After the onset of bypass, the anesthesiologist
suctions the lungs and removes the endotracheal tube.
F
t
s
p
c
c
w
t
Living lobar lung transplantation 53igure 7 The first allograft is placed on a cooling jacket within
he pleural space and the exposed lung is wrapped in iced,
aline-soaked sponges. The entire bronchial anastomosis is
erformed with running 4-0 polypropylene suture, intussus-
epting the donor bronchus to the recipient main stem bron-
hus. Using interrupted sutures on the cartilaginous portion
ithout invagination is also acceptable. Care is taken to limit
he amount of peribronchial dissection.Figure 8 The bronchial anastomosis places the donor lobar vein in
close approximation to the superior pulmonary vein of the recipient
and the venous anastomosis is performed in a running fashion with
5-0 polypropylene suture.
54 M.K. McLean, M.L. Barr, and V.A. StarnesFigure 9 The short length of the donor vein makes anastomosis directly to the left atrium difficult and underscores the
importance of leaving an adequate length of recipient pulmonary vein during pneumonectomy. The pulmonary artery
anastomosis is performed end-to-end with 5-0 polypropylene suture. A similar procedure is performed for the second
allograft.
After completing the bilateral implantations, the arterial vascular clamp is slowly removed. The preservation per-
fusate is permitted to egress from the venous anastomosis before tying the venous sutures, and ventilation is begun
gently. Continuous nitric oxide starting at 20 ppm and intermittent aerosolized bronchodilator therapy are both
administered via the anesthesia circuit. Blood volume is gradually returned, allowing increased cardiac ejection and
pulmonary blood flow to occur with subsequent weaning from cardiopulmonary bypass. At the completion of implan-
tation, transesophageal echocardiography to evaluate for patency of the one pulmonary vein on each side draining into
the left atrium and bronchoscopy to assess the bronchial anastomoses and for pulmonary toileting are performed. Four
chest tubes are then placed; the clamshell incision is closed, and the patient is transported directly to the intensive care
unit.
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Living lobar lung transplantation 55llograft Preservation
echnique
reparation of the donor lobe begins at the start of the donor
peration with a continuous prostaglandin infusion and me-
iculous attention to operative technique during the lobec-
omy. In contrast to standard deceased donor lung explanta-
ion, preservation of the lobe in a live donor does not permit
n situ flushing and cooling of the graft with cold preservation
olutions. Therefore, after the donor lobe is removed, it is
aken to a separate, sterile table for cold preservation. The
llograft is immersed in cold crystalloid solution. The pulmo-
ary artery and vein are cannulated in an alternating fashion
nd flushed with 1 to 2 liters of cold Perfadex (low potassium,
extran, glucose) solution until the pulmonary venous and
rterial effluents are clear and the parenchyma is blanched
hite. We initially used Euro-Collins solution but now use
erfadex (Vitrolife, Kungsbacka, Sweden) solution exclu-
ively. During perfusion, the lobe is gently ventilated with
oom air. A ventilation bag with different size endotracheal
ubes should be available. Using an appropriately sized en-
otracheal tube permits an adequate seal to be formed while
entilating the bronchus and prevents potential damage to
he bronchus caused by crushing or squeezing the bronchus
n an effort to obtain an adequate seal. Depending on the
ength of the bronchus, it may be necessary to selectively
ntubate the superior segment bronchus separately with a
maller tube to ventilate that portion of the lobe. The superior
egment artery may have to be perfused separately as well.
are must be taken to prevent the crystalloid bath or the
reservation solution effluent from flooding the bronchus. In
ddition, a manometer is fastened to the ventilation appara-
us and the lobe is inflated to a pressure of 20 to 25 mm Hg,
eing careful to avoid over-pressurizing the lung. After ade-
uate perfusion and ventilation, a final tidal volume is ad-
inistered to achieve approximately 75% maximum infla-
ion; the endotracheal tube is quickly removed, and the
ronchus is occluded with a noncrushing clamp. The donor
obe is placed in sterile bags with cold storage solution and
ransported to the recipient operating room in an ice-filled
ooler.
ostoperative Management
onor Management
he donors are transported to the recovery room with epi-
ural catheters in place after the lobectomy. Chest tubes are
equired until all evidence of air leak has ceased; chest tube
utput is acceptable, and the remaining lung tissue fills the
emithorax with no significant pneumothorax. Donors re-
eive low-dose enoxaparin and sequential compression de-
ices postoperatively to prevent thromboembolic complica-
ions.
ecipient Management
lthough immunosuppression, antibiotic therapy and pro-
hylaxis, and long-term management of the lobar recipient
re very similar to standard deceased donor lung transplan-
ation, the perioperative management is different given the
hysiology of lobar transplantation. aThe lobar physiology of the recipient presents unique chal-
enges compared with whole-lung transplantation, because
he entire cardiac output is flowing through two relatively
ndersized lobes. In an attempt to decrease atelectasis and
ptimize expansion of the lobes, the recipient is kept sedated
nd ventilated through a single lumen endotracheal tube
ith positive end-expiratory pressures of 5- to 10-cm water
or at least 48 hours. Additionally, efforts are undertaken to
ecrease pulmonary artery pressures and minimize the risk
f reperfusion injury and pulmonary edema. This is accom-
lished by maintaining the recipient in a relatively hypovo-
emic state, by the use of nitroglycerin infusion, and by the
se of aerosolized nitric oxide for the first 48 to 72 hours.
Another unique aspect of managing the lobar recipient in
he perioperative period is chest tube control. Depending on
he degree of size mismatch between the donor lobe and the
ecipient pleural cavity, conventional chest tube suction in
he postoperative period can result in impaired deflation me-
hanics. This can lead to air trapping with increasing airway
ressures, a rise in pulmonary vascular resistance, and sub-
equently, an acute rise in pulmonary arterial pressure. This
roblem is exaggerated as the discrepancy between the size of
he lobe and the thoracic cavity increases. To avoid this prob-
em, suction is applied at low levels (10-cm water) to each
ube sequentially for 1-hour intervals in a rotational fashion
or the first 24 hours postoperatively. Subsequently, each of
he four chest tubes is placed on continuous suction that is
radually increased to 20-cm water over the next 48 hours.
hest tube output can be much greater than that seen after
eceased donor whole-lung implantation as there is an oblig-
tory space filling of the pleural cavity with fluid, which can
e exacerbated by greater topographical mismatches. The
uestion of whether these tubes can be removed despite these
igher than normal outputs is unclear. However, because of
oncerns of lobe compression by the pleural fluid, the chest
ubes are left in place for 2 to 3 weeks, which is significantly
onger than for conventional transplantation. Residual air
eaks typically resolve in this time period as well.
onclusions
constant awareness of the risk to the living donors must be
aintained with any live donor organ transplantation pro-
ram, and comprehensive short- and long-term follow-up
hould be strongly encouraged to maintain the viability of
hese potentially lifesaving programs. This alternative proce-
ure has been lifesaving in severely ill patients who would
ither die or become unsuitable recipients before deceased
onor lungs became available. Although conventional trans-
lantation is preferable due to the risk to the donors, living
obar lung transplantation should continue to be utilized un-
er properly selected circumstances. Although there have
een no deaths in the donor cohort, a risk of death between
.5 and 1% should be quoted pending further data. Loss of
ung function should be considered an expected aspect of this
rocedure, and is explained as such, to the potential donor
uring the process of obtaining informed consent. The re-
ults reported by our group and others are important if this
rocedure is to be considered as an option at more pulmo-
ary transplant centers in view of the institutional, regional,
nd intra- and international differences in the philosophical
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56 M.K. McLean, M.L. Barr, and V.A. Starnesnd ethical acceptance of the use of live organ donors for
ransplantation.8,9
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